Page last updated: 2024-12-07

acranil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acranil: structure; fluorescent cpd for cytogenetic studies; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID101742
SCHEMBL ID11946676
MeSH IDM0048936

Synonyms (23)

Synonym
1-[(6-chloro-2-methoxy-acridin-9-yl)amino]-3-(diethylamino)propan-2-ol
2-propanol, 1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-
acranil
skf 16214-a2
chlorometacrine
1-[(6-chloro-2-methoxyacridin-9-yl)amino]-3-(diethylamino)propan-2-ol
522-20-3
SCHEMBL11946676
sn 186
z7b99z492d ,
1-((6-chloro-2-methoxyacridin-9-yl)amino)-3-(diethylamino)propan-2-ol
unii-z7b99z492d
einecs 208-324-6
2-methoxy-6-chlor-9-(3-diethylamino-2-hydroxypropylamino)acridin
chlormetacrine [mi]
2-propanol, 1-((6-chloro-2-methoxy-9-acridinyl)amino)-3-(diethylamino)-
chlormetacrine
1-(6-chloro-2-methoxy-9-acridylamino)-3-diethylamino-2-propanol
1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-2-propanol
1-[(6-chloro-2-methoxyacridin-9(10h)-ylidene)amino]-3-(diethylamino)propan-2-ol
DTXSID00966576
Q27295111
Z2574937069
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.18 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]